SLC5A2 and type 2 diabetes mellitus: Current treatment options, including glucose and blood pressure control, use of renin-angiotensin system blockers and, more recently, use of SGLT2 (sodium-glucose cotransporter-2) inhibitors in those with type 2 diabetes, slow disease progression.